Generally a weaker trading day and we've seen quite a bit of...

  1. 2,299 Posts.
    lightbulb Created with Sketch. 318
    Generally a weaker trading day and we've seen quite a bit of intraday price movements amongst Opportunity stocks, but they are holding well and a bit more time needed, we should expect to see the next price spurt.
    If CAT was not closed, the to-date gains would have been 95% instead of 31%, so patience is needed for the market to fully recognise the value potential of each stock and to absorb profit taking after delivering recent stellar run on the share price.

    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7
    0   OPPORTUNITY STOCKS Date stock mentioned in Its Over thread Open price on date stock mentioned 17/4/19 Close Change% Potential Upside
    1 1 XRO [XERO]   11/2/19   $ 46.200   $ 51.570 11.6% Phase 3-4 ; growth & getting in profitability
    2 2 MYE [MASTERMYNE]   11/2/19   $ 0.840   $   0.865 3.0% Phase 4- growth
    3 3 CLV [CLOVER]   11/2/19   $ 1.525   $   1.995 30.8% Phase 4- growth
    4 4 SFC [SCHAEFFER]   12/2/19   $ 14.480   $ 13.170 -9.0% Phase 4-growth
    5 5 YOW [YOWIE]   [closed]   19/2/19   $ 0.070 $   0.090 28.6% Phase 3-validated; shareholder conflict
    6 6 CAT [CATAPULT] [closed]   21/2/19   $ 0.640 $   0.840 31.3% Phase 3-validated; governance issue
    7 7 PME [PROMEDICUS]   21/2/19   $ 14.45   $   17.87 23.7% Phase 4-growth
    8 8 VHT [VOLPARA]   6/3/19   $ 1.185   $   1.875 58.2% Phase 2-3 -validating & ramping
    9 9 NST [NORTHERN STAR]   8/3/19   $    8.87   $ 8.66 -2.4% Phase 4- defensive growth
    10 10 ANO [ADVANCED NANOTEK] [re-opened]   8/3/19   $    3.05   $ 4.25 39.3% Phase 4-growth
    11 11 CYL [CATALYST METALS]   13/3/19   $    2.30   $ 2.07 -10.0% Phase 1-positive discovery
    12 12 NUH [NUHEARA] [closed]   13/3/19   $ 0.069 $   0.061 -11.6% Phase 1-2 nearing validation; governance issue
    13 13 MWY [MIDWAY]   14/3/19   $ 3.980   $   3.650 -8.3% Phase 4- growth
    14 14 D20 [DUXTON WATER]   27/3/19   $ 1.580   $   1.600 1.3% Phase 4-defensive growth & scalability
    15 15 PNV [POLYNOVO]   1/4/19   $ 0.760   $   0.910 19.7% Phase 2-3- validated & ramping & getting into profitability
    16 16 DUB [DUBBER]   8/4/19   $ 0.925   $   0.965 4.3% Phase 2-3- validated & ramping
    17 17 TTT [TITOMIC]   8/4/19   $ 2.300   $   2.450 6.5% Phase 1-positive discovery
    18 18 EVS [ENVIROSUITE]   10/4/19   $ 0.170   $   0.165 -2.9% Phase 2-3- validated & ramping
    19 19 AD8 [AUDINATE]   10/4/19   $ 6.290   $   6.350 1.0% Phase 3- validated, ramping into profitable growth
    20   LOTTERY STOCKS          
    21 20 4DS [4DS]   20/2/19   $ 0.067   $   0.074 10.4% Phase 1-positive discovery
    22 21 BIT [BIOTRON]   20/2/19   $ 0.090   $   0.093 3.3% Phase 1-positive discovery
    23 22 ACW [ACTINOGEN]   20/2/19   $ 0.054   $   0.054 0.0% Phase 1-positive discovery
    24   COMPOSITE RETURN%       10.4%  
    25   SMALL CAP ORDS RETURN% SINCE 11/2/19       5.0%  
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.